cancer clinical trials for Lymphoma/CLL (ONC)
21 Lymphoma/CLL (ONC) clinical trials found. View a list of all cancer clinical trial types.
-
A Phase I, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Current Status: Not Open
View links and contact information related to this clinical trial -
:A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of Rondecabtagene Autoleucel, a CD19/CD20 Dual Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
Phase III Randomized Controlled Trial to Compare LYL314, a Dual Targeting CD19/CD20 CAR T-Cell Product Candidate, Versus Investigator's Choice of CD19 CAR T-Cell Therapy in Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Second-Line Setting
Current Status: Open
View links and contact information related to this clinical trial -
Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®)
Current Status: Open
View links and contact information related to this clinical trial -
The ROSE Study - Research On Survivorship Experiences. Disparities in cancer-related outcomes between rural and non-rural cancer survivors in the catchment areas of the Big 10 Cancer Research Consortium's Population Science Working Group
Current Status: Open
View links and contact information related to this clinical trial -
A First-In-Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies
Current Status: Open
View links and contact information related to this clinical trial -
A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib
Current Status: Open
View links and contact information related to this clinical trial -
Randomized, Open-label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)
Current Status: Open
View links and contact information related to this clinical trial -
Phase II Study of Dual Targeting of CD19 and CD20 Antigens Using Sequential CD19-directed CAR-T Cells Followed by Mosunetuzumab or Glofitamab in Relapsed or Refractory Diffuse Large B-cell or Transformed Follicular Lymphomas
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I Study of IM-1021 in Participants with Advanced Malignancies
Current Status: Open
View links and contact information related to this clinical trial -
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel
Current Status: Open
View links and contact information related to this clinical trial -
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel
Current Status: Open
View links and contact information related to this clinical trial -
A Phase Ib, Open Label, Global, Multicenter, Dose Determination, Randomized Dose Expansion Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of Iberdomide (CC-220) in Combination With R-CHOP-21 and CC-99282 in Combination With R-CHOP-21 for Subjects With Previously Untreated Aggressive B-cell Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release
Current Status: Open
View links and contact information related to this clinical trial -
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed or Refractory CD10-Negative Diffuse-Large B-Cell Lymphoma (DLBCL) and High-Grade B-Cell Lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I, multicenter, open-label study of UB-VV111 in combination with Rapamycin in relapsed or refractory (R/R) CD19+ B-Cell malignancies
Current Status: Open
View links and contact information related to this clinical trial -
An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Phase III Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)
Current Status: Open
View links and contact information related to this clinical trial -
A Pilot, Randomized, Double-blind, Placebo-controlled Study using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy in Multiple Myeloma and Lymphoma: The PRIMAL Trial
Current Status: Open
View links and contact information related to this clinical trial -
An Observational Study Associating Adiponectin Signaling with Acute and Chronic Toxicity Following Pelvic Radiation
Current Status: Open
View links and contact information related to this clinical trial